Neurocognition in Marginalized Populations
The C3 Lab is interested in the neuropsychological functioning of persons who are homeless and precariously housed. We are exploring how cognition relates to real-world functioning in this group, and how this is impacted by multimorbidity and aging. We are further interested in developing practical ways to improve overall functional outcomes for marginalized persons who face many barriers to accessing health services.
Neuropsychological Impacts of COVID-19
We are currently investigating the neurocognitive, psychological, and social impacts of symptomatic COVID-19 infection in Canadian adults in collaboration with researchers at the University of Victoria. Our study uses teleneuropsychology to remotely assess participants. To learn more about this study, please visit our website.
Neurocognitive Markers of Aging and Dementia
We are interested in identifying cognitive markers of premature or accelerated aging, and Alzheimer's disease and related dementias. Our work leverages data from large-scale longitudinal studies of aging to examine subtle neurocognitive and brain changes in the preclinical stages of disease. Collaborative projects facilitate the integration of neurocognitive, neuroimaging, and molecular data to address novel questions about brain-behaviour relationships in aging.
The Hotel Study
In conjunction with the University of British Columbia and Simon Fraser University, the Hotel Study is a large, naturalistic 20-year study investigating the barriers to better health and wellness among persons living in homelessness or precarious housing. Principal investigators: Dr. William Honer (UBC Psychiatry) and Dr. Allen Thornton (SFU Psychology).
Canadian Longitudinal Study on Aging (CLSA)
The CLSA is a national study of over 50,000 persons who are being followed for up to 20 years to examine the biological, psychological, and social determinants of successful aging.
Rush Alzheimer's Disease Centre (RADC)
Located at Rush University, the RADC is conducting epidemiological, clinical, and laboratory research aimed towards identifying risk factors and brain pathology, and improving diagnosis and treatment of Alzheimer's disease and other dementias.